OrbiMed Rides IPO Wave To Huge New Fund
This article was originally published in Start Up
Executive Summary
While many life science VCs have raised smaller, more focused funds recently, OrbiMed Advisors has closed on a $735 million venture fund, the second-largest life science fund since the financial crisis.